FO-5
- Molecular, cellular and higher levels targeting
- Systems for targeted delivery of drugs, peptides, proteins, growth factors, gene therapy agents and vaccines
- Carrier materials: liposomes, micelles, dendrimers, micro/ nanocapsules, hydrogels, molecularly imprinted polymers, macromolecular conjugates, mesoporous inorganic materials
- Drug targeting and targeting and imaging agents to site/specific delivery
- Antibody targeting
- Controlled release systems
- Bioinorganics and metal ion releasing systems
- Theranostic nanoparticles: synthesis and characterisation
- Pharmacokinetics and pharmacodynamics
- In-vitro and in-vivo studies and models for drug transport, absorption metabolism and retention mechanisms
- Clinical applications
- Biocompatibility and safety issues
- Nanotheranostic platforms for cancer, cardiology, CNS disorders